Jan, 2018: Construction of the new facility of Mailian Medical completed
June: Trial of the first series of non-invasive continuous monitoring system for real-time monitoring of blood pressure per heartbeat for use in O.R. and ICU completed
September: Announcement from Zhejiang Food and Drug Administration that the non-invasive continuous blood pressure per heartbeat monitoring system enters the special approval procedure for type II innovative medical device.
October: Opening of Mailian Medical’s new facility
November: Non-invasive continuous blood pressure per heartbeat monitoring system passed special approval of innovative medical device, type II, by Zhejiang Food and Drug Administration
June: Establishment of Zhejiang Mailian Medical Equipment Co., Ltd.
August: Establishment of Zhejiang Mailian Medical Co., Ltd.’s R&D Dept.